0000000001187323

AUTHOR

William Lang

showing 1 related works from this author

Preliminary clinical efficacy and safety of BMN 701, GILT-tagged recombinant human acid alpha glucosidase (rhGAA), in late-onset Pompe disease: resul…

2014

Metachromatic leukodystrophy (MLD) is a lysosomal disorder that results from the deficiency of the lysosomal enzyme arylsulfatase A. It is characterized by motor and developmental regression, seizures, deafness, blindness, dementia and premature death. There are three types of onsets: late infantile, juvenile, and adult. We performed a retrospective chart review of 71 patients (47 infantile, 23 juvenile) evaluated at the Program for Study of Neurodevelopment in Rare Disorders (NDRD) between January 2000 and August 2013. The patients were evaluated prospectively using a standardized protocol. The purpose of the study is to describe the natural course of the disease. In 31 patients only a bas…

Newborn screeningPediatricsmedicine.medical_specialtybusiness.industryEndocrinology Diabetes and MetabolismLate onsetDiseasemedicine.diseaseBiochemistryVirologyMetachromatic leukodystrophyEndocrinologyGeneticsmedicineDementiaJuvenileAge of onsetbusinessMolecular BiologyDevelopmental regressionMolecular Genetics and Metabolism
researchProduct